Search

Author/Creator Vilar, E

1. Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge. (21st November 2018)

Authors:
Parseghian, C M; Loree, J M; Morris, V K; Liu, X; Clifton, K K; Napolitano, S; Henry, J T; Pereira, A A; Vilar, E; Johnson, B; Kee, B; Raghav, K; Dasari, A; Wu, J; Garg, N; Raymond, V M; Banks, K C; Talasaz, A A; Lanman, R B; Strickler, J H
Journal:
Annals of oncology
Issue:
Volume 30:Number 2(2019)
Page Start:
243
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2. (23rd August 2018)

Authors:
Chang, K; Willis, J A; Reumers, J; Taggart, M W; San Lucas, F A; Thirumurthi, S; Kanth, P; Delker, D A; Hagedorn, C H; Lynch, P M; Ellis, L M; Hawk, E T; Scheet, P A; Kopetz, S; Arts, J; Guinney, J; Dienstmann, R; Vilar, E
Journal:
Annals of oncology
Issue:
Volume 29:Number 10(2018)
Page Start:
2061
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer. (23rd October 2017)

Authors:
Overman, M J; Adam, L; Raghav, K; Wang, J; Kee, B; Fogelman, D; Eng, C; Vilar, E; Shroff, R; Dasari, A; Wolff, R; Morris, J; Karunasena, E; Pisanic, R; Azad, N; Kopetz, S
Journal:
Annals of oncology
Issue:
Volume 29:Number 1(2018)
Page Start:
139
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer. (3rd July 2018)

Authors:
Overman, M J; Adam, L; Raghav, K; Wang, J; Kee, B; Fogelman, D; Eng, C; Vilar, E; Shroff, R; Dasari, A; Wolff, R; Morris, J; Karunasena, E; Pisanic, T R; Azad, N; Kopetz, S
Journal:
Annals of oncology
Issue:
Volume 30:Number 3(2019)
Page Start:
495
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis. Issue 2 (30th May 2022)

Authors:
Samadder, N Jewel; Foster, Nathan; McMurray, Ryan P; Burke, Carol A; Stoffel, Elena; Kanth, Priyanka; Das, Rohit; Cruz-Correa, Marcia; Vilar, E; Mankaney, Gautam; Buttar, Navtej; Thirumurthi, Selvi; Turgeon, Danielle K; Sossenheimer, Michael; Westover, Michelle; Richmond, Ellen; Umar, Asad; Della...
Journal:
Gut
Issue:
Volume 72:Issue 2(2023)
Page Start:
256
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗